Podinour-XP 281.25mg Injection
Marketer
Nourier Lab
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Podinour-XP 281.25mg Injection
Xylocomb 281.25mg injection is a dual-action antibiotic, indicated for a range of bacterial infections. Its mechanism combats microbial proliferation, thus curbing infection spread. Administration must be strictly under medical guidance. Complete the prescribed dosage regimen; premature cessation may reduce effectiveness. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening symptoms to your physician promptly. Seek immediate medical attention for allergic reactions (rash, pruritus, edema, dyspnea). Disclose all current medications to your doctor before commencing treatment. Pregnant or lactating individuals should consult their physician. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, refrain from operating vehicles if experiencing somnolence or vertigo. Adequate rest, balanced nutrition, and hydration promote optimal recovery. Your doctor may request laboratory and imaging studies to monitor treatment efficacy.
Primary Ingredients of Podinour-XP 281.25mg Injection
No text was provided to rewrite.
Uses of Podinour-XP 281.25mg Injection
Infections caused by bacteria
Major Benefits of Podinour-XP 281.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Podinour-XP 281.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Podinour-XP 281.25mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Podinour-XP 281.25mg Injection works:
Ceftriaxone and Tazobactum, the components of Podinour-XP 281.25mg Injection, act synergistically to combat bacterial infections. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. Tazobactum, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Podinour-XP 281.25mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Podinour-XP, 281.25mg, is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human clinical trials remain scarce.
Breast feedingCAUTION
The administration of Podinour-XP 281.25mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Podinour-XP 281.25mg Injection could lead to reduced alertness, impaired vision, drowsiness, and dizziness. Driving should be avoided if any of these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding Podinour-XP 281.25mg Injection use in individuals with renal impairment is scarce. Seek medical advice from your physician.
LiverCAUTION
For individuals with severe hepatic impairment, administering Podinour-XP 281.25mg Injection requires careful consideration and potential dose modification. Medical advice is essential. Dosage alteration of Podinour-XP 281.25mg Injection is unnecessary for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Podinour-XP 281.25mg Injection :
Should you inadvertently omit a dose of Podinour-XP 281.25mg Injection, seek medical advice.
Facts to Know About Podinour-XP 281.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently